24 June 2021 CAN PHARMACEUTICAL COMPANIES COUNTER THE WAIVER OF THEIR PATENTS FOR COVID-19 VACCINES THROUGH INVESTMENT TREATY ARBITRATION?
Since the COVID-19 outbreak, pharmaceutical companies have engaged in a highly competitive and risky vaccine...